NL191432C - Farmaceutisch preparaat omvattende naproxen en een andere werkzame verbinding. - Google Patents

Farmaceutisch preparaat omvattende naproxen en een andere werkzame verbinding.

Info

Publication number
NL191432C
NL191432C NL8320240A NL8320240A NL191432C NL 191432 C NL191432 C NL 191432C NL 8320240 A NL8320240 A NL 8320240A NL 8320240 A NL8320240 A NL 8320240A NL 191432 C NL191432 C NL 191432C
Authority
NL
Netherlands
Prior art keywords
naproxen
pharmaceutical composition
active compound
another active
another
Prior art date
Application number
NL8320240A
Other languages
English (en)
Dutch (nl)
Other versions
NL191432B (nl
NL8320240A (nl
Original Assignee
Vicks Richardson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicks Richardson filed Critical Vicks Richardson
Publication of NL8320240A publication Critical patent/NL8320240A/nl
Publication of NL191432B publication Critical patent/NL191432B/xx
Priority to NL9500644A priority Critical patent/NL9500644A/nl
Priority to NL9500645A priority patent/NL9500645A/nl
Application granted granted Critical
Publication of NL191432C publication Critical patent/NL191432C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NL8320240A 1982-07-22 1983-07-21 Farmaceutisch preparaat omvattende naproxen en een andere werkzame verbinding. NL191432C (nl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NL9500644A NL9500644A (nl) 1982-07-22 1995-06-27 Farmaceutisch preparaat omvattende fenoprofen.
NL9500645A NL9500645A (nl) 1982-07-22 1995-06-27 Farmaceutisch preparaat omvattende diflunisal.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
US40059782 1982-07-22
PCT/US1983/001121 WO1984000488A1 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US8301121 1983-07-21

Publications (3)

Publication Number Publication Date
NL8320240A NL8320240A (nl) 1984-06-01
NL191432B NL191432B (nl) 1995-03-01
NL191432C true NL191432C (nl) 1995-07-04

Family

ID=23584242

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8320240A NL191432C (nl) 1982-07-22 1983-07-21 Farmaceutisch preparaat omvattende naproxen en een andere werkzame verbinding.

Country Status (15)

Country Link
JP (3) JPS59501460A (xx)
AT (2) AT389226B (xx)
AU (1) AU558485B2 (xx)
BE (1) BE897356A (xx)
CA (1) CA1217429A (xx)
CH (1) CH659391A5 (xx)
DE (1) DE3390116C2 (xx)
FR (1) FR2530469A1 (xx)
GB (1) GB2134786B (xx)
IE (1) IE55367B1 (xx)
IT (1) IT1206502B (xx)
NL (1) NL191432C (xx)
SE (1) SE466481B (xx)
WO (1) WO1984000488A1 (xx)
ZA (2) ZA835324B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
CH669523A5 (xx) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
CN1551770A (zh) 2001-07-06 2004-12-01 ������ҩ�����޹�˾ 羟吗啡酮控释制剂
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (ja) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd 疲労回復剤
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP7523879B2 (ja) * 2016-10-31 2024-07-29 エスエス製薬株式会社 医薬組成物
JP2021054728A (ja) * 2019-09-27 2021-04-08 興和株式会社 医薬品
JP6811453B1 (ja) * 2020-06-24 2021-01-13 医療法人すぎやま内科 経皮吸収用組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Also Published As

Publication number Publication date
SE8401538D0 (sv) 1984-03-20
GB2134786A (en) 1984-08-22
SE466481B (sv) 1992-02-24
AT389226B (de) 1989-11-10
IT8322173A0 (it) 1983-07-21
ZA835324B (en) 1984-09-26
GB2134786B (en) 1986-05-08
IE831715L (en) 1984-01-22
JPS59501459A (ja) 1984-08-16
AU558485B2 (en) 1987-01-29
ATA903983A (de) 1989-04-15
BE897356A (fr) 1983-11-14
CA1217429A (en) 1987-02-03
IT1206502B (it) 1989-04-27
NL191432B (nl) 1995-03-01
GB8406704D0 (en) 1984-04-18
FR2530469A1 (fr) 1984-01-27
WO1984000488A1 (en) 1984-02-16
IE55367B1 (en) 1990-08-29
ATA245988A (de) 1989-08-15
AT389998B (de) 1990-02-26
JPH07165583A (ja) 1995-06-27
DE3390116C2 (de) 1994-06-16
NL8320240A (nl) 1984-06-01
DE3390116T1 (de) 1985-01-10
SE8401538L (sv) 1984-03-20
AU1881683A (en) 1984-02-23
ZA835326B (en) 1984-09-26
JPS59501460A (ja) 1984-08-16
CH659391A5 (de) 1987-01-30

Similar Documents

Publication Publication Date Title
NL193419B (nl) Topicaal toepasbare farmaceutische samenstellingen.
IT8322171A0 (it) Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina.
BR1100036A (pt) Composto e composição farmacêutica
DE3486255D1 (de) Pharmazeutische Zusammensetzungen.
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
ES520749A0 (es) Cosechadora perfeccionada.
FR2547727B1 (fr) Compositions pharmaceutiques
DE3485408D1 (de) Pharmazeutische zusammensetzung.
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
NL188905C (nl) Anthracyclineverbinding en farmaceutisch preparaat.
NL191432C (nl) Farmaceutisch preparaat omvattende naproxen en een andere werkzame verbinding.
IT1206693B (it) Composizioni migliorate analgesiche e antiinfiammatorie contenenti ibuprofen.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
IT1213453B (it) Composizione farmaceutica.
MX9203639A (es) 3-fenoxi-1-azetidincarboxamidas y composiciones farmaceuticas que las contienen.
ES519865A0 (es) Una composicion extruible y reticulable.
BE896711A (fr) Compositions pharmaceutiques anti-ulceres.
DE3483900D1 (de) Pharmazeutische zusammensetzungen.
IT8548964A0 (it) 8alfa-acilamminoergoline,loro preparazione e composizioni farmaceutiche che le contengono
DZ276A1 (fr) Préparations pharmaceutiques.
IT1206323B (it) Preparazioni farmaceutiche con azione citostatica.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
OA07489A (fr) Composition pharmaceutique antihypertensive synergétique.
IT1197578B (it) Alcaloidi ergopeptidici,loro preparazione e medicamenti contenenti questi composti
IT8222757A0 (it) Composizione farmaceutica antiateromasica.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20030721